Osteoporosis News and Research

Latest Osteoporosis News and Research

Eating disorders - hitting early and hard

Children as young as seven have been admitted to hospitals for eating disorders. A peak support group has reported a doubling of calls about children under the age of 12 in the past decade. Being hit so early with these disorders also means malnutrition leading to retarded growth, osteoporosis, infertility and changes in brain structure say experts.

30 Mar 2011

Study: Gene combinations may increase risk of hip osteoporosis in women

Women with osteoporosis in their hip suffer menopause two years earlier than healthy women, a study conducted at the University of Granada says. Additionally, although further study is required, researchers have found at least three genetic markers associated with osteoporosis in the hip in postmenopausal women.

30 Mar 2011

Osseon launches Osseoflex BT Steerable Bone Tamp for physicians

Osseon Therapeutics announced today at the Society of Interventional Radiology's Annual Meeting the launch of the Osseoflex BT Steerable Bone Tamp.

30 Mar 2011

CytRx to present bafetinib preclinical study results at AACR Annual Meeting

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies demonstrating that its oncology drug candidate bafetinib inhibits bone destruction in model systems is being presented on April 2, 2011 at the American Academy for Cancer Research 102nd Annual Meeting in Orlando, Florida.

29 Mar 2011

Prostate cancer updates

A Hunter-based prostate cancer support group says ground-breaking research by the University of Newcastle will help save many lives in the region. This new work has found patients with localized advanced prostate cancer can double their chances of survival by undertaking hormone therapy in combination with radiology treatment. This comes from a 10 year trial, coordinated by the University's Professor Jim Debnam.

28 Mar 2011

Bionovo initiates enrollment in Menerba Phase 1 clinical trial for menopausal hot flushes

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that enrollment has started for the Phase 1 clinical trial testing the safety of two doses of Menerba in postmenopausal women for the treatment of menopausal hot flushes (study # MF101-008), also known as "menopausal hot flashes."

28 Mar 2011

$Osteoporotic hip and vertebral fractures have most serious impact on quality of life$

Osteoporotic hip and vertebral fractures have most serious impact on quality of life

A study presented today at the European Congress on Osteoporosis and Osteoarthritis currently taking place in Valencia, Spain has found that the initial quality of life loss following an osteoporotic fracture is substantial, especially with regard to hip and vertebral fractures. The study found differences in quality of life loss between countries after correcting for other explanatory variables.

25 Mar 2011

$Obese postmenopausal women as likely to fracture as non-obese women$

Obese postmenopausal women as likely to fracture as non-obese women

Obesity is widely believed to be protective against fracture, although a recent study has documented a high prevalence of obesity in postmenopausal women with fragility fracture.

25 Mar 2011

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

25 Mar 2011

Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates

Protelos has significantly greater bone-forming activity than the commonly prescribed bisphosphonate, alendronate, according to results of the largest-ever biopsy study in post-menopausal women presented today at the European Congress on Osteoporosis and Osteoarthritis in Valencia.

25 Mar 2011

$Falls history improves accuracy of fracture prediction models$

Falls history improves accuracy of fracture prediction models

Researchers from the MRC Lifecourse Epidemiology Unit in Southampton, UK, have presented a new study that shows how the inclusion of falls history, in addition to clinical risk factors (CRFs) and bone mineral density (BMD) values, would greatly improve the accuracy of fracture prediction models. The research findings were presented today at the European Congress on Osteoporosis & Osteoarthritis in Valencia, Spain.

25 Mar 2011

$ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro$

ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro

Research presented today at the European Congress on Osteoporosis & Osteoarthritis by investigators from the UK and Sweden estimates that the economic burden of fragility fractures in five major European countries totals 31 billion Euro, with Germany bearing the highest costs.

25 Mar 2011

Electromagnetic radiation from cellular phones may affect bone strength

Electromagnetic radiation from cellular phones may adversely affect bone strength, suggests a study in the March Journal of Craniofacial Surgery. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

25 Mar 2011

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.

25 Mar 2011

Experts to present latest advances in bone research at annual European meeting

Today, the European Congress on Osteoporosis and Osteoarthritis opened in Valencia, Spain with some 4000 international participants. The Congress is the major annual European meeting in the bone field and attracts clinicians, specialists and bone experts from around the world. ECCEO11-IOF continues until March 26th at Valencia's Palacio de Congresos.

24 Mar 2011

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Amgen today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis.

24 Mar 2011

$Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty$

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Medtronic of Canada Ltd. today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients.

23 Mar 2011

Breast cancer updates

Many survivors of breast cancer cite stress as a link to the cancer despite no scientific proof of a connection. Experts believe that the root cause here are the lifestyle-related issues - such as smoking and obesity - where there is a clear link to the cancer.

22 Mar 2011

IOF, Fonterra Brands award 10,000 USD to OSPFI for Bone Health Campaign

The Osteoporosis Society of the Philippines Foundation Inc was awarded the first IOF-Anlene Nutrition Awareness for Bone Health Campaign Grant at a presentation ceremony that took place at the IOF World Wide Conference of Osteoporosis Patient Societies in Valencia, Spain on March 20, 2011.

22 Mar 2011

EDMA endorses the campaign against excessive use of salt

EDMA, the European Diagnostic Manufacturers Association, fully endorses the 2011 World Salt Awareness Week theme “Salt and Men’s Health” as the latter reminds that more men than women die prematurely of cardiovascular diseases (CVD).

21 Mar 2011

Osteoporosis News and Research

Latest Osteoporosis News and Research

Eating disorders - hitting early and hard

Study: Gene combinations may increase risk of hip osteoporosis in women

Osseon launches Osseoflex BT Steerable Bone Tamp for physicians

CytRx to present bafetinib preclinical study results at AACR Annual Meeting

Prostate cancer updates

Bionovo initiates enrollment in Menerba Phase 1 clinical trial for menopausal hot flushes

Osteoporotic hip and vertebral fractures have most serious impact on quality of life

Obese postmenopausal women as likely to fracture as non-obese women

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates

Falls history improves accuracy of fracture prediction models

ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro

Electromagnetic radiation from cellular phones may affect bone strength

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Experts to present latest advances in bone research at annual European meeting

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Breast cancer updates

IOF, Fonterra Brands award 10,000 USD to OSPFI for Bone Health Campaign

EDMA endorses the campaign against excessive use of salt

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Osteoporosis News and Research

Latest Osteoporosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in